Article on Rotaject® Technology featured in World Pharmaceutical Frontiers

B News Page 740x540

The growing demand for treatments using biological drugs has created a challenge for injectable devices to deliver next-generation, high viscosity formulations all the while putting patient comfort and usability first. Building upon more than 10 years of experience with autoinjectors for highly viscous drugs, SHL’s Rotaject® technology is the ultimate solution for this challenge.

This groundbreaking technology has been featured in the 2017 spring edition of World Pharmaceutical Frontiers magazine. To learn more about the Rotaject® technology, read the full article HERE.

About SHL

SHL Group is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,000 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit www.shl.group

Share:

Related News